VX-118

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Cystic Fibrosis

Phase 1

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

CompletedNCT06154447

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2023-12-12End: 2026-07-10Updated: 2026-08-10

A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet Formulation

CompletedNCT06312787

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2024-04-02End: 2024-05-04Updated: 2024-06-03